Landscape and progress of global COVID-19 vaccine development

Hum Vaccin Immunother. 2021 Oct 3;17(10):3276-3280. doi: 10.1080/21645515.2021.1945901. Epub 2021 Jul 13.

Abstract

The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has affected billions of lives globally, and the world hopes to end this epidemic by effective vaccination. In this review, we depict the latest panorama of global COVID-19 vaccine research and development based on different technology platforms, and summarize key characteristics and available evidence on vaccines authorized for emergency use, in order to provide insights into improve coordination in the COVID-19 outbreak response for related stakeholders.

Keywords: COVID-19; Clinical trial; lanscape; vaccine.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • SARS-CoV-2
  • Vaccination
  • Vaccines*

Substances

  • COVID-19 Vaccines
  • Vaccines

Grants and funding

The data analysis and interpretation were supported by the Chinese Academy of Medical Sciences’ Initiative for Innovative Medicine [grant 2020-I2M-2-007].